Haifa, Israel

Lior Gepstein

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Hafia, IL (2007)
  • Haifa, IL (2009 - 2012)

Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Lior Gepstein: Innovator in Medical Sciences

Introduction

Lior Gepstein is a prominent inventor based in Haifa, Israel, known for his significant contributions to the field of medical sciences. With a focus on ion channel research, he has developed innovative solutions that address various medical conditions.

Latest Patents

Gepstein holds 4 patents, with his latest inventions focusing on polynucleotides and polypeptides related to human KV1.3. One of his notable patents describes an isolated polypeptide that includes a first amino acid sequence homologous to specific coordinates of SEQ ID NO: 2, along with a tryptophan residue and a second homologous amino acid sequence. This invention has potential applications in treating medical conditions associated with ion channel insufficiency. Another significant patent involves nucleic acid constructs and methods for modifying the electrophysiological function of excitable tissues, providing new avenues for treating diseases caused by dysfunction in these tissues.

Career Highlights

Throughout his career, Lior Gepstein has worked with esteemed organizations such as Genegrafts Ltd. and the Rappaport Family Institute for Research in the Medical Sciences. His work has been instrumental in advancing the understanding and treatment of ion channel-related medical issues.

Collaborations

Gepstein has collaborated with notable colleagues, including Yair Feld and Shimon Marom, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Lior Gepstein's work exemplifies the intersection of innovation and medical research, showcasing his dedication to improving health outcomes through scientific advancements. His patents and collaborations continue to influence the medical sciences landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…